~/blog/delta-8-november-12-or-december-11-subclause
Is Delta-8 Banned November 12 or December 11? Read the Text
Section 2019 names subclause (iv)(I) only. Converted delta-8 sits under (iv)(II), so on the statute's words its date is December 11, not November 12.
Is delta-8 banned on November 12 or December 11? On the enrolled text, December 11. Section 2019 of H.R. 6500 keeps only subclauses (ii)(I) and (iv)(I) live before that date: cannabinoids the plant cannot produce. If the plant can produce delta-8, as Mary Jane’s Bakery Co states, converted delta-8 is a subclause (II) product, which section 2019 does not name.
That is the answer. The rest of this piece is the map: the clause that decides it, the clause the two camps of blogs are actually arguing about, and the one document that could still change the sorting.
Why two dates are circulating for delta-8
Ten days after the President signed H.R. 6500, the top results for this exact question disagree with each other. One hemp retailer’s blog, updated 8 September, says delta-8 loses hemp status on 12 November. Another, dated 7 September, says 11 December. A law firm’s explainer and a cannabis news hub describe the carve-out accurately and, in the sections we read, do not place delta-8 on either date.
None of the four quotes the subclauses that decide it. So we read them, on 11 September 2026, from the Government Publishing Office’s own copies.
What section 2019 of H.R. 6500 actually delays
The enrolled text of H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, carries the hemp material as section 2019, headed “Section 781 Extension.” Its operative sentence:
“Until December 11, 2026, the amendments made by section 781 of division B of Public Law 119-37 (7 U.S.C. 1639o note) shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I) of section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) (as amended by such section 781).”
Read it as a scope limit, not a date change. We made that point on 4 September, and it is the whole reason the two-date question exists. The 12 November effective date was never repealed. For 29 days the redefinition narrows to two subclauses, and everything the question turns on is which subclauses those are.
They are (ii)(I) and (iv)(I). Not (ii)(II). Not (iv)(II). The Roman numeral is doing all the work.
The three subclauses of section 781, side by side
Section 781 of Public Law 119-37 is written to take effect “365 days after the enactment of this Act,” and it rewrites section 297A of the Agricultural Marketing Act of 1946. Among other things it removes two classes of hemp-derived cannabinoid product from the hemp definition: intermediates, in paragraph (ii), and final products, in paragraph (iv). Each paragraph has three subclauses, and the first two are identical between them. Here they are as printed, with our labels.
| Subclause | Statutory text (final products, paragraph (iv)) | What it reaches | Live from |
|---|---|---|---|
| (iv)(I) | cannabinoids that are “not capable of being naturally produced by a Cannabis sativa L. plant” | Molecules the plant cannot make at all | November 12, 2026 |
| (iv)(II) | cannabinoids that “(aa) are capable of being naturally produced by a Cannabis sativa L. plant; and (bb) were synthesized or manufactured outside the plant” | Molecules the plant can make, but this batch was made in a lab | December 11, 2026 |
| (iv)(III) | “greater than 0.4 milligrams combined total per container” of total tetrahydrocannabinols and similar cannabinoids | Potency, regardless of origin | December 11, 2026 |
Paragraph (ii), for intermediate products, mirrors (I) and (II) word for word and swaps (III) for a “more than 0.3 percent combined total” test. Section 2019 names (ii)(I) and (iv)(I) and stops.
Notice what is not in those subclauses, as printed: the word “synthetic.” Section 781 does not sort cannabinoids into natural and synthetic. It sorts them by whether the plant can make them, and then, for the ones it can, by whether this particular batch was made by the plant. Those are two different questions, and they get two different dates.
Where converted delta-8 falls
The delta-8 on the market is described as “converted” product on the pages we read; Mary Jane’s and The Haze Connect both use that word, and none of the four, in the sections we read, says otherwise. So the (bb) prong of subclause (II), “synthesized or manufactured outside the plant,” is satisfied on its face for converted delta-8. The (aa) prong asks whether delta-8 is “capable of being naturally produced” by the plant.
Here is the premise the whole answer rests on, so we will state it as a premise. Mary Jane’s Bakery Co, the exact-match incumbent, writes that “the plant does make these in trace amounts.” Trade coverage we saw in the search results reads it the same way. We did not find a primary scientific or FDA source in this run that settles it, and section 781 itself hands the question to FDA: the statute directs a list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature.” As of 3 September, per Hemp Law Group, and as of our own search on 28 August, that list had not been published.
So the honest form of the answer is conditional, and the condition is a narrow one. If delta-8 is a cannabinoid the plant can produce, converted delta-8 sits under subclause (II), section 2019 does not name (II), and delta-8 products keep their federal hemp status until 11 December. If the FDA list, when it arrives, were to say the plant cannot produce delta-8, then (I) would reach it and the date would be 12 November. Mary Jane’s states the first reading outright, and no page we read, on either side of the date dispute, applies the “not capable of being naturally produced” test to delta-8. The disagreement is not about the chemistry. It is about which subclause the delay names, and the delay names (I).
One thing the (II) point does not do: it does not save the product. A converted delta-8 gummy at any consumer dose will also fail the 0.4 milligram per-container ceiling in (iv)(III) on 11 December, as we worked through in August. The subclause question decides which clause reaches delta-8 and when, not whether it survives.
The product-class map, by subclause and date
Reading the same three subclauses across the product classes people actually search for, the map looks like this. The molecule-level placements of HHC and THC-O are the incumbents’ characterisation, not our measurement.
| Product class | Subclause that reaches it first | Federal date | Basis |
|---|---|---|---|
| HHC, THC-O products | (iv)(I), if the plant cannot make them | November 12, 2026 | All four pages read place them here; not verified against FDA or peer-reviewed literature by this desk |
| Converted delta-8 and delta-10 products | (iv)(II) | December 11, 2026 | Plant can make them per the pages read; this batch was made outside the plant |
| THCa flower and plant-derived concentrates | Headline total-THC definition (THCa now counted) | December 11, 2026 | Not a (I) cannabinoid; reached when the delta-9-only yardstick is replaced |
| Hemp delta-9 gummies, chocolates, drinks | (iv)(III), the 0.4 mg per-container ceiling | December 11, 2026 | Potency, regardless of how the delta-9 was made |
| Full-spectrum CBD above 0.4 mg total THC per container | (iv)(III) | December 11, 2026 | Same ceiling; depends on formulation |
Two cautions on the map. First, the dates are federal hemp-definition dates. What follows for a product that leaves the definition is a controlled-substance question the text does not settle, and for HHC in particular the DEA has its own listing history, which we covered on 22 August, that runs independently of section 781. Second, the map says nothing about your state, which we come back to below.
What the four incumbent pages say, and why they split
This is the table we wish one of them had printed. Each row is what the page says about delta-8’s date, in its own words, and the reason it gives.
| Page | Dated | Delta-8 date | Reason given | Cites (I) or (II)? |
|---|---|---|---|---|
| Mary Jane’s Bakery Co | 7 September 2026 (“last verified”) | December 11 | “The plant does make these in trace amounts, so the delay reaches them” | No |
| The Haze Connect | Updated 8 September 2026 | November 12 | “Synthetic and converted cannabinoids such as Delta-8, HHC and THC-O still lose hemp status on November 12, 2026” | No |
| Hemp Law Group | Current as of 3 September 2026 | Not stated in the sections we read | Describes the carve-out as “cannabinoids the cannabis plant cannot naturally produce”; lists delta-8 only as counted within total THC | No |
| Herb | 12 August 2026, updated to the 2 September signing | Not stated | Takeaways: synthetics the plant “can’t” produce keep November 12; mechanisms section: anything “synthesized or manufactured outside the plant” is excluded, which “catches delta-8” | No |
Read down the table and the split is visible. The Haze Connect puts delta-8 on 12 November because it is “converted.” Converted is the (bb) prong of subclause (II). The page is describing (II) and assigning it (I)‘s date. Mary Jane’s reaches 11 December for the right reason, half-stated: trace natural production is the (aa) prong, and (aa) plus (bb) is (II), which section 2019 leaves alone. Herb describes both subclauses in different paragraphs without noticing they carry different dates. Hemp Law Group describes (I) correctly and simply never asks where delta-8 goes.
The split, in other words, is not natural versus synthetic. It is (I) versus (II). Every page treats “synthetic,” “lab-made” and “converted” as one bucket, and the statute has two.
How the dates were set in the first place
Section 781 runs from “365 days after the enactment” of Public Law 119-37. Hemp Law Group, Herb and Mary Jane’s all put that enactment on 12 November 2025, which yields 12 November 2026; we did not reach the approval line on the govinfo page in the window we read, so treat the enactment date as borrowed. December 11, 2026 is written into section 2019 directly and is also the day the funding in the same bill runs out, which is why the delay is 29 days and not a round number.
The votes and the signing are on the public record and on the Hemp Law Group, Haze Connect and Mary Jane’s pages: the Senate passed the bill 90 to 6 on 8 August after tabling an amendment to strip the hemp language 61 to 32, the House accepted the Senate version 370 to 48 on 1 September, and the President signed it on 2 September. We sourced the signing to the White House’s own notice in the 4 September piece linked above rather than re-asserting it here.
The state layer does not move
A federal calendar moving does not move anybody else’s. The Haze Connect’s own 8 September update makes the point for the other side of the date argument: “State dates (Texas, Illinois, Philadelphia) do not move.” We have not fetched those state or city instruments in this run, so take the three names as that page’s list, not ours. The mechanism is not in doubt, though. State delta-8 cut-offs sit in state statutes and shift when legislatures shift them, which is the whole reason the state patchwork looks the way it does. A reader in a state that has already closed the door on delta-8 gets nothing from 11 December. Check your state, then check the date on the instrument, not the date in the headline.
Is delta-8 banned on November 12 or December 11, 2026?
On the enrolled text, December 11. Section 2019 of H.R. 6500 keeps only subclauses (ii)(I) and (iv)(I) live before that date, and those cover cannabinoids the plant cannot produce. Mary Jane’s Bakery Co states the plant makes delta-8 in trace amounts, and no page we read applies the ‘not capable of being naturally produced’ test to it; that puts converted delta-8 under subclause (II), which section 2019 does not name. FDA’s unpublished cannabinoid list would settle the classification.
Which cannabinoids still lose hemp status on November 12, 2026?
Only products containing cannabinoids that are ‘not capable of being naturally produced by a Cannabis sativa L. plant’, the subclause (I) test. The four pages we read on 11 September all put HHC and THC-O in that group; none of them cites a primary source for that placement, and neither can we. The FDA list of naturally producible cannabinoids, which section 781 calls for, is the document that would settle it.
Is delta-8 considered synthetic under the federal hemp ban?
The exclusion subclauses of section 781, as we read them, do not use the word ‘synthetic’. They draw two lines: cannabinoids the plant cannot produce at all, and cannabinoids the plant can produce but which ‘were synthesized or manufactured outside the plant’. Converted delta-8 fits the second description on its face. Both groups leave the hemp definition; the only difference is that the second group does so on December 11, not November 12.
What did the September 2 hemp delay actually change?
It changed scope for 29 days, not the rules. Section 2019 of H.R. 6500 says that until December 11, 2026 the section 781 amendments ‘shall only apply’ to products in subclauses (ii)(I) and (iv)(I). The total-THC definition, the 0.3 percent intermediate test, the 0.4 milligram per-container ceiling and the (II) exclusion all wait until December 11. Nothing was softened.
Is THCa flower still legal until December 11, 2026?
Federally, THCa flower is not touched by the November 12 slice, because THCa is a cannabinoid the plant produces and subclause (I) does not reach it. From December 11 the definition switches to total tetrahydrocannabinols including THCa, which most smokable flower will not pass. Federal hemp status is not state legality, and state cut-off dates did not move with the federal delay, so check your state.
Reading the map
The short version fits on an index card. Section 2019 names subclause (I). Converted delta-8 is a subclause (II) product if the plant can produce delta-8, which is what Mary Jane’s states and no page we read contradicts in the statute’s own terms. (II) waits for 11 December, and so, on the statute’s own words, does delta-8. The one open variable is a list FDA has been directed to publish and, as of the dates above, had not.
Nothing in either act authorises or approves any product or brand; section 781 redraws a definition and section 2019 narrows it for 29 days, nothing more. What a product does when it leaves that definition is a question these pages do not answer, and a date in federal statute is not a date in yours. Check your state. Nothing here is health guidance, no effect is promised by anyone, and none of it is for anyone under 21.